Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,899 public trials 2,122 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation

NCT04280081

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiated Hospital Of Guangzhou Medical University Guangzhou, Guangdong, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 36 locations
View Trial Details
Active, not recruiting

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

NCT05868265

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, not recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

NCT05483868

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Tower Urology Los Angeles, California, United States
  • Saint John's Cancer Institute Santa Monica, California, United States
  • Montefiore Medical Center The Bronx, New York, United States
View all 19 locations
View Trial Details
Active, not recruiting

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

NCT04919122

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • State University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Ochsner Clinic Foundation d/b/a Ochsner Health New Orleans, Louisiana, United States
  • The Johns Hopkins University Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Active, not recruiting

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

NCT06160752

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +24 more
Locations
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • The Ohio State University Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions